Skip to content

I wish I had more to offer

Nothing here but dreams

Sibel Announces its 4th FDA Clearance for Continuous Wearable Vital Signs Monitoring with ANNE® One and Additional Strategic Collaboration with Ann & Robert H. Lurie Children’s Hospital of Chicago







Sibel Announces its 4th FDA Clearance for Continuous Wearable Vital Signs Monitoring with ANNE® One and Additional Strategic Collaboration with Ann & Robert H. Lurie Children’s Hospital of Chicago





























Expanded Indication Includes Adolescents, Ambulatory ECG, Continuous SpO2, and Non-Invasive Blood Pressure in the Home or Hospital Setting.

CHICAGO, Feb. 7, 2024 /PRNewswire/ — Sibel Health, a leading digital health company, announced today that its continuous wearable monitoring solution, ANNE® One, has received another 510(k) clearance from the U.S. Food and Drug Administration (FDA). The ANNE® One platform now allows for continuous ambulatory ECG monitoring, SpO2, temperature, and non-invasive blood pressure measurements. In addition, this new clearance extends the population to include individuals 12 years and above for monitoring in the home and hospital settings.

Sibel Announces its 4th FDA Clearance for Continuous Wearable Vital Signs Monitoring with ANNE® One and Additional Strategic Collaboration with Ann & Robert H. Lurie Children's Hospital of Chicago (PRNewsfoto/Sibel Health)
Sibel Announces its 4th FDA Clearance for Continuous Wearable Vital Signs Monitoring with ANNE® One and Additional Strategic Collaboration with Ann & Robert H. Lurie Children’s Hospital of Chicago (PRNewsfoto/Sibel Health)

Steve Xu MD, Co-Founder and CEO of Sibel Health, said “Our mission here at Sibel Health is to deliver Better Health Data for All®. Our zero-cable wearable platform allows patients to be fully untethered while still being continuously monitored for all core vital signs whether you’re in the hospital or at home.” The extension into the adolescent population is particularly important to Sibel Health, a company founded on a strong commitment to pediatric medical device development. In 2021, Sibel Health was one of 5 innovation finalists in the National Capital Consortium for Pediatric Device Innovation funded by the FDA to support advancement of pediatric medical devices. The next year Sibel Health received FDA clearance for ANNE® Pediatrics – a miniaturized version of ANNE® One—indicated for monitoring key vital signs in neonates including those born with extreme prematurity. “We want to ensure that we offer advanced wireless monitoring for all pediatric patients from neonates to adolescents. This takes us one step closer,” says Anne-Séverine Lima Pimenta, General Manager of Clinical Care at Sibel Health.

Sibel Health also announces a new collaboration with Ann & Robert H. Lurie Children’s Hospital of Chicago and its research enterprise, Stanley Manne Children’s Research Institute. “We’re pleased to be working with Sibel Health, a startup right in our own backyard, to demonstrate the value of continuous monitoring in the home setting. The needs of children with medical complexity and disability require new technology solutions that are family centric and innovative,” says Carolyn C. Foster, MD, MS, Assistant Professor of Pediatrics at Northwestern University Feinberg School of Medicine and Director of the Health@Home Digital Healthcare Research Initiative at Stanley Manne Children’s Research Institute. This collaboration is further supported by a major philanthropic gift to the Ann & Robert H. Lurie Children’s Hospital of Chicago Foundation, from Claire Cheney and Mark Ethier, founder of iZotope. This gift will enable Sibel Health and Lurie Children’s to expand its collaboration to other avenues of research in advanced wireless monitoring for children with Dr. Jeremy Wong, Assistant Professor of Pediatrics (Neurology and Epilepsy). “I have had the pleasure of working with Sibel on their next generation neuromonitoring solutions over the last two years. I am excited for the opportunity to leverage Claire and Mark’s generosity to further this collaboration to greater heights to enhance the care of neonates and children” says Dr. Wong.

About Sibel Health:
Sibel Health is an award-winning digital health company with a mission to deliver Better Health Data for All®. Based in Chicago with an international office in Seoul, the company’s FDA-cleared ANNE® platform includes advanced wearable sensors, AI-enabled data analytics, and an integrated mobile software and cloud platform. Sibel’s partnerships include some of the most respected healthcare organizations worldwide. For more information, please visit us at www.sibelhealth.com and follow us on LinkedIn.

About Lurie Children’s:

Research at Ann & Robert H. Lurie Children’s Hospital of Chicago is conducted through Stanley Manne Children’s Research Institute. Manne Research Institute is focused on improving child health, transforming pediatric medicine, and ensuring healthier futures through the relentless pursuit of knowledge. Lurie Children’s is a nonprofit organization committed to providing access to exceptional care for every child. It is ranked as one of the nation’s top children’s hospitals by U.S. News & World Report. Lurie Children’s is the pediatric training ground for Northwestern University Feinberg School of Medicine.

SOURCE Sibel Health

Also from this source

By signing up you agree to receive content from us.
Our newsletters contain tracking pixels to help us deliver unique content based on each subscriber’s engagement and interests. For more information on how we will use your data to ensure we send you relevant content please visit our PRN Consumer Newsletter Privacy Notice. You can withdraw your consent at any time in the footer of every email you’ll receive.
Mit Ihrer Anmeldung erklären Sie sich damit einverstanden, Inhalte von uns zu erhalten.
Unsere Newsletter enthalten Zählpixel, die die Lieferung einzigartiger Inhalte in Bezug auf das Abonnement und die Interessen der einzelnen Abonnenten ermöglichen. Weitere Informationen über die Verwendung Ihrer Daten im Hinblick auf die Zusendung von relevanten Inhalten, finden Sie in unserer PRN Consumer Newsletter Privacy Notice. Ihre Zustimmung können Sie jederzeit in der Fußzeile jeder erhaltenen E-Mail widerrufen.
En vous inscrivant à la newsletter, vous consentez à la réception de contenus de notre part.
Notre newsletter contient des pixels espions nous permettant la fourniture à chaque abonné, d’un contenu unique en lien avec ses souscriptions et intérêts. Pour de plus amples informations sur l’utilisation faite de vos données en vue de l’envoi des contenus concernés, nous vous invitons à consulter la politique de confidentialité disponible à partir du lien suivant PRN Consumer Newsletter Privacy Notice. Vous pouvez à tout moment revenir sur votre consentement par le biais des informations situées au bas de chaque e-mail reçu.
Регистрирайки се, Вие се съгласявате да получавате информационно съдържание от нас. Нашите бюлетини съдържат проследяващи пиксели, които ни помагат да предоставяме уникално съдържание въз основа на ангажираността и интересите на всеки абонат. За повече информация относно начина, по който ще използваме Вашите данни, за да гарантираме, че Ви изпращаме подходящо съдържание, моля, направете справка с нашето Уведомление за поверителност на потребителския бюлетин на PRN. Можете да оттеглите съгласието си по всяко време в долния колонтитул на всеки от имейлите, които ще получите.

Go to Source

Published February 7, 2024By PR Newswire Online News
Categorized as Automotive, Newswire Tagged Strategy

Post navigation

Previous post

@Geely-Volvo: Volvo Cars in collaboration to establish a mobility innovation centre for emerging technologies

Next post

G-SHOCK Unveils the GMAP2100 Series: A Stylish Fusion of Design in a Sized Down Version for Women

Not much to see here… sorry for that

I wish I had more to offer
Proudly powered by WordPress.